Cellectar Biosciences
CLRB
7 hedge funds and large institutions have $5.13M invested in Cellectar Biosciences in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
32% less capital invested
Capital invested by funds: $7.52M → $5.13M (-$2.39M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$546K |
| 2 |
AIC
AWM Investment Company
New York
|
-$91K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $3.1M | -$91K | -1 | -1% |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $1.04M | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $751K | -$546K | -6 | -32% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $88K | +$91K | +1 | New |
|
|
BA
5
Bard Associates
Chicago,
Illinois
| $77K | – | – | – |
|
6
Goldman Sachs
New York
| $50K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $9K | – | – | – |
|
8
Morgan Stanley
New York
| $5K | – | – | – |
|
|
BCM
9
Brookstone Capital Management
Wheaton,
Illinois
| $4K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
SSB
11
Sandy Spring Bank
Olney,
Maryland
| $1K | – | – | – |
|
CLRB Hedge Fund Activity: Q3 2015 in Review
7 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q3 2015, worth a combined $5.13M — down 32% from $7.52M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CLRB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $91K. The largest seller was Sabby Management, cutting an estimated $546K.
- 7 institutional investors held Cellectar Biosciences (CLRB) as of Q3 2015, up from 6 in Q2 2015.
- Funds reported $5.13M of Cellectar Biosciences stock for Q3 2015, down 32% quarter-over-quarter.
- 1 fund opened new Cellectar Biosciences positions in Q3 2015 and 0 closed out, a net change of +1 holder.
- The largest Cellectar Biosciences buyer in Q3 2015 was Geode Capital Management, an estimated $91K added.
- The largest Cellectar Biosciences seller in Q3 2015 was Sabby Management, an estimated $546K sold.
Based on aggregated 13F filings for Q3 2015.